Coronavirus (COVID-19) Nucleocapsid Antibody

Product code: 11-2003

Clonality : Polyclonal
Application : ELISA, WB

Shipping Info:

Order now and get it on Wednesday June 26, 2024

Write a review for this product on BioCompare
Get $20 gift card from Amazon

Available Pack Size(s)

  •   25 µg

  •  100 µg

  • $100.00 

  • $270.00 

Add to Wish List

Shipping Info:

Order now and get it on Wednesday June 26, 2024

Same day delivery FREE on San Diego area orders placed by 1.00 PM

Format : Purified
Amount : 100 µg
Isotype : Rabbit IgG
Purification : Protein A Chromatography
Content : 25 µg in 50 µl/100 µg in 200 µl PBS containing 0.05% BSA and 0.05% sodium azide. Sodium azide is highly toxic.
Storage condition : Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.
Immunogen Information : A partial length recombinant coronavirus Nucleocapsid protein (amino acids 250-410) was used as the immunogen for this antibody.

The structural nucleocapsid (N) protein of nCoV/SARS-CoV-2/COVID-19 is a predicted 46 kDa phosphoprotein having 419 amino acid residues. A short Serine rich stretch and a recognized nuclear localization signal are the unique features of the nucleocapsid protein of nCoV/SARS-CoV-2/COVID-19, which seems to have a little homology with the proteins of other members of this large corona virus family. These features also suggest the involvement of nucleocapsid protein of nCoV/SARS-CoV-2/COVID-19 in different stages of viral lifecycle. The protein has multifaceted activities including packing of the nCoV/SARS-CoV-2/COVID-19 viral genome into a helical ribonucleocapsid (RNP) and playing an important role in viral self-assembly causing nCoV/SARS-CoV-2/COVID-19. The nucleocapsid protein of nCoV/SARS-CoV-2/COVID-19 also forms dimer in the cell by self-association with the help of interactive C terminal domain.

Recommended dilutions: WB: 0.5-1 µg/ml. However, this need to be optimized based on the research applications.

For Research Use Only. Not for use in diagnostic/therapeutics procedures.

Shradha Mawatwal, Amruta Mohapatra, Sayani Das, Aisurya Ray, Ratnadeep Mukherjee, Gulam Syed, Shantibushan Senapati, Balachandran Ravindran
Prior exposure to malaria decreases SARS-CoV-2 mediated mortality in K18-hACE2 mice without influencing viral load in lungs
Section for Immunology, Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway

There are currently no product reviews

Customers who purchased this product also purchased

Most viewed Products